Five-year Single-blind, Phase III Effectiveness Randomised Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis: Prednisone Versus Prednisone Plus Cyclosporine a Versus Prednisone Plus Methotrexate
Phase: PHASE3
Conditions: Juvenile Dermatomyositis
Sponsor: Istituto Giannina Gaslini

COVER PAGE 
Official title: “FIVE-YEAR SINGLE-BLIND, PHASE III EFFECTIVENESS RANDOMISED 
ACTIVELY CONTROLLED CLINICAL TRIAL IN NEW ONSET JUVENILE 
DERMATOMYOSITIS: PREDNISONE VERSUS PREDNISONE PLUS CYCLOSPORINE A 
VERSUS PREDNISONE PLUS METHOTREXATE” 
NCT number: NCT00323960 
Document date: 23rd February 2007